STAT News questions over-dosing in cancer drug trials

STAT News reported that many cancer drug trials might be using doses far higher than necessary. This practice could be causing severe side effects, impacting patients' quality of life and potentially even treatment effectiveness. It's a call for pharmaceutical companies to re-evaluate how they set drug dosages.